Daily feed · SEC Form 4 filings
All insider sales — Jul 24, 2017
Every open-market insider sale (transaction code S, price above zero). Gifts, tax withholding, and other $0 dispositions are not sales and are excluded — they appear on the filing pages labelled as what they are.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2017 SForm 4 → | Jul 21, 8:04 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Jeffrey M LeidenCEO & President, Director | 216,624 | $160.96 | $34,868,222 | 257,392 | −45.7% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:43 pm EDT | Nuveen California Quality Municipal Income FundNAC | BARCLAYS PLC10% Owner | 260 | $100,000.00 | $26,000,000 | 1,041 | −20.0% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 8:09 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Ian F SmithEVP, CFO & COO | 133,750 | $160.98 | $21,530,813 | 115,888 | −53.6% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 7:58 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Stuart A ArbuckleEVP\Chief Commercial Officer | 101,875 | $161.50 | $16,453,101 | 121,117 | −45.7% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 24, 11:06 am EDT | JOHNSON & JOHNSONJNJ | Dominic J CarusoExec VP, Finance; CFO | 82,591 | $136.72 | $11,291,478 | 144,102 | −36.4% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 8:02 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Jeffrey ChodakewitzEVP GMDA, CMO | 46,733 | $160.96 | $7,522,135 | 114,424 | −29.0% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 8:10 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Paul M SilvaSVP & Corp Controller | 43,443 | $161.07 | $6,997,456 | 16,634 | −72.3% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 5:56 pm EDT | HP INCHPQ | Margaret C WhitmanDirector | 295,936 | $19.00 | $5,622,784 | 470,889 | −38.6% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 6:11 pm EDT | SCHWAB CHARLES CORPSCHW | Joseph R MartinettoSenior EVP | 115,642 | $42.10 | $4,868,528 | 155,916 | −42.6% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 8:00 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | David AltshulerEVP, Global Research and CSO | 28,979 | $161.00 | $4,665,619 | 106,011 | −21.5% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 8:07 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Amit SachdevEVP, CRO | 28,625 | $160.93 | $4,606,691 | 90,710 | −24.0% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:05 pm EDT | CF CorpCFCOU | BlueMountain Capital Management, LLC +310% Owner | 367,460 | $10.98 | $4,034,711 | 2,318,764 | −13.7% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:29 pm EDT | Arista Networks, Inc.ANET | Jayshree UllalPresident and CEO, Director | 22,763 | $157.81 | $3,592,219 | 2,736,564 | −0.82% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 21, 6:28 pm EDT | Facebook IncFB | Christopher K CoxChief Product Officer | 16,000 | $164.28 | $2,628,483 | 196,871 | −7.52% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 9:00 pm EDT | VARONIS SYSTEMS INCVRNS | Ohad KorkusChief Technology Officer, Director | 57,938 | $39.04 | $2,262,050 | 214,108 | −21.3% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:06 pm EDT | UNIVERSAL DISPLAY CORP \PA\OLED | Steven V AbramsonPresident and CEO, Director | 18,000 | $124.53 | $2,241,609 | 253,480 | −6.63% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:21 pm EDT | FISERV INCFISV | Jeffery W YabukiPresident and CEO, Director | 17,000 | $126.02 | $2,142,340 | 286,151 | −5.61% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 9:49 pm EDT | Sarepta Therapeutics, Inc.SRPT | Sandesh MahatmeEVP, CFO & CBO | 50,000 | $41.00 | $2,050,000 | 32,361 | −60.7% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:30 pm EDT | CADENCE DESIGN SYSTEMS INCCDNS | Thomas P BeckleySr. Vice President | 56,250 | $35.00 | $1,968,936 | 266,484 | −17.4% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 21, 4:55 pm EDT | ADOBE SYSTEMS INCADBE | Abhay ParasnisEVP & CTO | 12,500 | $149.38 | $1,867,205 | 12,623 | −49.8% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 8:05 pm EDT | VERTEX PHARMACEUTICALS INC / MAVRTX | Michael PariniEVP, CL&AO | 10,829 | $161.00 | $1,743,469 | 28,809 | −27.3% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:57 pm EDT | ADOBE SYSTEMS INCADBE | Donna MorrisEVP, Cust. & Emp. Experience | 10,000 | $150.00 | $1,500,000 | 65,083 | −13.3% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:05 pm EDT | UNIVERSAL DISPLAY CORP \PA\OLED | Julia J BrownChief Technical Officer | 10,000 | $125.00 | $1,250,000 | 162,932 | −5.78% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:05 pm EDT | MORGAN STANLEYMS | Jonathan PruzanChief Financial Officer | 25,767 | $46.68 | $1,202,834 | 196,708 | −11.6% | plan? |
| Jul 18, 2017 SForm 4 → | Jul 21, 4:32 pm EDT | Spark Energy, Inc.SPKE | W Keith Maxwell III +2Director, 10% Owner | 56,400 | $21.23 | $1,197,362 | 639,780 | −8.10% | plan? late amended |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:33 pm EDT | BOINGO WIRELESS INCWIFI | David HaganChief Executive Officer, Director | 75,000 | $15.27 | $1,145,500 | 596,853 | −11.2% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 5:25 pm EDT | ACADIA PHARMACEUTICALS INCACAD | Glenn BaityEVP AND GC | 38,097 | $30.00 | $1,142,910 | 71,156 | −34.9% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 9:46 pm EDT | Sarepta Therapeutics, Inc.SRPT | David T HowtonSVP, General Counsel | 25,000 | $41.00 | $1,025,000 | 22,301 | −52.9% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 5:27 pm EDT | Emergent BioSolutions Inc.EBS | Fuad El-HibriChairman, Director, 10% Owner | 25,000 | $35.50 | $887,500 | 1,655,216 | −1.49% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:01 pm EDT | INCYTE CORPINCY | Steven H SteinEVP & Chief Medical Officer | 6,485 | $131.09 | $850,119 | 18,165 | −26.3% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:05 pm EDT | ENTEGRIS INCENTG | Gregory B GravesEVP & CFO | 32,593 | $26.01 | $847,639 | 60,646 | −35.0% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:40 pm EDT | NCI BUILDING SYSTEMS INCNCS | Norman C ChambersExecutive Chairman, Director | 45,000 | $17.74 | $798,489 | 476,403 | −8.63% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:03 pm EDT | SYSCO CORPSYY | Wayne ShurtsExecutive Vice President | 15,600 | $50.87 | $793,572 | 50,976 | −23.4% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 5:47 pm EDT | Jazz Pharmaceuticals plcJAZZ | Suzanne Sawochka HooperEVP & General Counsel | 4,580 | $160.00 | $732,800 | 32,322 | −12.4% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 24, 10:35 am EDT | EAGLE BANCORP INCEGBN | Janice L. WilliamsEVP/CCO | 10,000 | $63.17 | $631,707 | 65,690 | −13.2% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:06 pm EDT | ICF International, Inc.ICFI | John WassonPresident & COO | 12,461 | $47.50 | $591,898 | 53,534 | −18.9% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 24, 1:58 pm EDT | COMMERCE BANCSHARES INC /MO/CBSH | David W KemperChairman of the Board, CEO, Director | 10,132 | $57.83 | $585,942 | 1,227,014 | −0.82% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:48 pm EDT | Wright Medical Group N.V.WMGI | Jennifer S. WalkerSVP, Process Improvement | 20,000 | $28.00 | $560,000 | 28,513 | −41.2% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:05 pm EDT | AGIOS PHARMACEUTICALS INCAGIO | Lewis Clayton Cantley Jr.Director | 9,000 | $56.36 | $507,260 | 85,237 | −9.55% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 9:36 pm EDT | Nabriva Therapeutics Legacy plcNBRV | HBM Healthcare Investments (Cayman) Ltd.10% Owner | 44,231 | $10.50 | $464,426 | 2,397,922 | −1.81% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 9:47 pm EDT | Sarepta Therapeutics, Inc.SRPT | Shamim RuffSVP, Regulatory Affairs & Qual | 10,638 | $42.82 | $455,572 | 21,062 | −33.6% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 9:48 pm EDT | Sarepta Therapeutics, Inc.SRPT | Edward M. Kaye M.D.Director | 10,000 | $41.00 | $410,000 | 52,471 | −16.0% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:18 pm EDT | NEOGEN CORPNEOG | Edward BradleyVice President | 5,000 | $66.33 | $331,657 | 86,512 | −5.46% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:58 pm EDT | KMG CHEMICALS INCKMG | David L Hatcher10% Owner | 6,000 | $51.17 | $306,990 | 1,688,097 | −0.35% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:12 pm EDT | AeroVironment IncAVAV | Timothy E ConverDirector | 7,600 | $38.19 | $290,208 | 1,987,135 | −0.38% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:05 pm EDT | MYR GROUP INC.MYRG | Gerald B. Engen Jr.Senior VP, CLO and Secretary | 8,790 | $31.23 | $274,470 | 58,295 | −13.1% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 24, 9:15 am EDT | Accenture plcACN | Julie Spellman SweetGroup Chief Exec-North America | 1,974 | $128.68 | $254,012 | 14,082 | −12.3% | plan? |
| Jul 17, 2017 SForm 4 → | Jul 21, 8:54 pm EDT | QUALSTAR CORPQBAK | William J Gervais10% Owner | 30,000 | $8.20 | $245,900 | 255,558 | −10.5% | plan? late |
| Jul 20, 2017 SForm 4 → | Jul 21, 9:45 pm EDT | Sarepta Therapeutics, Inc.SRPT | Alexander CumboSVP, Chief Commercial Officer | 5,918 | $41.00 | $242,638 | 16,875 | −26.0% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:22 pm EDT | ANALOG DEVICES INCADI | Margaret K SeifSVP, CLO & Secretary | 3,000 | $80.35 | $241,050 | 19,404 | −13.4% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:03 pm EDT | Proto Labs IncPRLB | Robert BodorVP/General Manager-Americas | 3,259 | $72.02 | $234,711 | 16,578 | −16.4% | plan? |
| Jul 18, 2017 SForm 4 → | Jul 24, 3:46 pm EDT | SolarEdge Technologies IncSEDG | Zvi LandoVice President, Global Sales | 10,508 | $22.19 | $233,148 | 46,011 | −18.6% | plan? late |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:07 pm EDT | Five9, Inc.FIVN | Daniel P. BurklandEVP Global Sales and Services | 10,000 | $22.35 | $223,500 | 163,498 | −5.76% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 6:21 pm EDT | Civitas Solutions, Inc.CIVI | Linda De Renzo* See Remarks | 10,000 | $18.83 | $188,300 | 181,334 | −5.23% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:41 pm EDT | FINJAN HOLDINGS, INC.FNJN | BCPI Corp +410% Owner | 53,500 | $3.46 | $185,050 | 4,046,285 | −1.30% | plan? |
| Jul 18, 2017 SForm 4 → | Jul 24, 3:49 pm EDT | SolarEdge Technologies IncSEDG | Rachel PrishkolnikVP General Counsel | 7,500 | $22.19 | $166,437 | 26,814 | −21.9% | plan? late |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:15 pm EDT | UNITED THERAPEUTICS CorpUTHR | Martine A RothblattChairman & CEO, Director | 1,236 | $131.62 | $162,683 | 140 | −89.8% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 21, 7:05 pm EDT | Aimmune Therapeutics, Inc.AIMT | Douglas T. SheehySee Remarks | 7,460 | $21.66 | $161,558 | 0 | −100% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:57 pm EDT | MERCER INTERNATIONAL INC.MERC | Eric LauritzenDirector | 13,000 | $12.22 | $158,860 | 69,085 | −15.8% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:19 pm EDT | PLEXUS CORPPLXS | Oliver K. MihmRegional President - EMEA | 2,749 | $54.87 | $150,838 | 4,923 | −35.8% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:47 pm EDT | Zendesk, Inc.ZEN | John GeschkeCLO and SVP Administration | 5,000 | $29.02 | $145,110 | 10,202 | −32.9% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 6:26 pm EDT | ELLIE MAE INCELLI | Sigmund AndermanFounder & Executive Chairman, Director | 1,319 | $109.90 | $144,958 | 98,321 | −1.32% | plan? |
| Jul 24, 2017 SForm 4 → | Jul 24, 11:37 am EDT | EAGLE BANCORP INCEGBN | Antonio F MarquezEVP/CLO-CRE | 2,200 | $63.04 | $138,695 | 18,773 | −10.5% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 6:25 pm EDT | Civitas Solutions, Inc.CIVI | Denis M. HollerChief Financial Officer | 6,937 | $19.10 | $132,497 | 316,507 | −2.14% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 5:41 pm EDT | EVERBRIDGE, INC.EVBG | Cintawati W. PutraOther | 4,940 | $23.51 | $116,150 | 279,417 | −1.74% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 5:27 pm EDT | EVERBRIDGE, INC.EVBG | Nicholas S. A. HawkinsManaging Director, EMEA | 4,891 | $23.15 | $113,236 | 0 | −100% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:20 pm EDT | GENOMIC HEALTH INCGHDX | Phillip G. FebboChief Medical Officer | 3,174 | $33.57 | $106,538 | 17,800 | −15.1% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 6:07 pm EDT | NxStage Medical, Inc.NXTM | Matthew W TowseSVP and Chief Financial Office | 4,300 | $24.16 | $103,888 | 24,421 | −15.0% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 6:28 pm EDT | NxStage Medical, Inc.NXTM | Winifred L SwanSVP and General Counsel | 3,500 | $24.16 | $84,560 | 13,270 | −20.9% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:43 pm EDT | Clearside Biomedical, Inc.CLSD | Daniel H. WhitePresident and CEO, Director | 8,000 | $9.75 | $78,000 | 37,709 | −17.5% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 21, 5:42 pm EDT | ATHENAHEALTH INCATHN | Jonathan D. PorterSVP, Network Services | 422 | $154.00 | $64,988 | 18,281 | −2.26% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 21, 4:55 pm EDT | INFINERA CorpINFN | David F WelchPresident, Director | 5,000 | $12.00 | $60,000 | 528,150 | −0.94% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 24, 6:04 am EDT | FINJAN HOLDINGS, INC.FNJN | Seed Iv L P Israel10% Owner | 14,891 | $3.48 | $51,837 | 3,152,365 | −0.47% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:47 pm EDT | Zendesk, Inc.ZEN | Adrian McDermottPresident of Products | 1,766 | $29.11 | $51,408 | 80,290 | −2.15% | plan? |
| Jul 18, 2017 SForm 4 → | Jul 21, 6:27 pm EDT | Cannabis Sativa, Inc.CBDS | David TobiasPresident, Director, 10% Owner | 8,656 | $4.60 | $39,816 | 4,240,490 | −0.20% | plan? late |
| Jul 20, 2017 SForm 4 → | Jul 24, 10:36 am EDT | Neenah Paper IncNP | James R PiedmonteSVP, Operations | 369 | $81.50 | $30,074 | 2,436 | −13.2% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 9:00 pm EDT | INTERCEPT PHARMACEUTICALS INCICPT | Daniel G WelchDirector | 217 | $126.76 | $27,507 | 3,710 | −5.53% | plan? |
| Jul 21, 2017 SForm 4 → | Jul 24, 2:35 pm EDT | FULTON FINANCIAL CORPFULT | Michael J DePorterPrincipal Accounting Officer | 1,500 | $18.00 | $27,000 | 806 | −65.0% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 8:15 pm EDT | Corium International, Inc.CORI | Joseph J. SarretChief Business Officer | 2,038 | $8.95 | $18,232 | 7,462 | −21.5% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 24, 6:02 am EDT | FINJAN HOLDINGS, INC.FNJN | Seed Iv L P Israel10% Owner | 2,570 | $3.50 | $8,990 | 3,167,256 | −0.08% | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:02 pm EDT | SCHOLASTIC CORPSCHL | Judith NewmanEVP, President, Book Clubs | 101 | $46.25 | $4,671 | 13,984 | −0.72% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.